From Fairfax 'Business Day' Today
A bullish trading update from Mayne Pharma helped push the shares ahead a sharp 7.5 per cent to 79 cents, putting it within sight of its all-time high of 83.5 cents touched earlier in the year.
Earlier today it flagged a December half net profit of between $8.2 and $8.4 million on revenue of $68 to $71 million.
This is a reversal from the year earlier net loss of $4.3 million on revenue of just $27.4 million.
Mayne Pharma has undergone a dramatic overhaul, with acquisitions and new drug roll-outs accounting for the growth.
The solid first half performance puts earnings on track to meet the Wilson HTM forecast of a full-year net profit of $17.3 million.
Ann: Mayne Pharma results and product update , page-3
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.71 |
Change
0.070(1.51%) |
Mkt cap ! $400.7M | |||
| Open | High | Low | Value | Volume |
| $4.67 | $4.75 | $4.62 | $953.1K | 203.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1236 | $4.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.72 | 620 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MYX (ASX) Chart |